Sharp Edge Labs

Sharp Edge Labs

Sharp Edge Labs

Sharp Edge Labs is developing next generation biosensors based on the Fluorogen Activating Peptide technology of co-Founders Alan Waggoner and Marcel Bruchez
Founded
2011
Raised
$600k
Follow us
Alexa global traffic share
Twitter followers
Latest funding
Undisclosed amount
Venture capital (Series C) - 2017
Innovation Works
$600,000
Venture capital (Series B) - 2014
Team Size
2
Employees

No recent coverage

Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when Sharp Edge Labs makes some noise.